Canada markets closed

Cyber Enviro-Tech, Inc. (CETI)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1700-0.0400 (-19.05%)
At close: 03:31PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.2100
Open0.2300
BidN/A x N/A
AskN/A x N/A
Day's Range0.1700 - 0.2300
52 Week Range0.1200 - 0.6200
Volume26,664
Avg. Volume23,968
Market Cap13.916M
Beta (5Y Monthly)-1.08
PE Ratio (TTM)34.00
EPS (TTM)0.0050
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • PR Newswire

    CYBER ENVIRO-TECH, INC IS FILING AN APPLICATION TO UPGRADE TO OTCQB MARKETPLACE

    (OTC Pink: CETI), Cyber Enviro-Tech, Inc. (CETI) is pleased to announce it is filing a formal application to upgrade its trading platform from the Pink Open Market (Pink), aka OTC Pink, to the OTCQB (Over-The-Counter Quotation Bureau). This advancement will mark a pivotal step forward as companies listed on the OTCQB market place are required to go through more rigorous reporting requirements including PCAOB* audited financial statements. In contrast, companies listed on the Pink Open Market are

  • PR Newswire

    CYBER ENVIRO-TECH, INC EXPANDS INTO THE MEAT AND FOOD PROCESSING INDUSTRIES

    (OTC Pink: CETI), Cyber Enviro-Tech, Inc. (CETI) is pleased to announce its exclusive disinfection biochemicals and processes designed for the meat and food processing industries. The meatpacking industry, notorious for its environmental impact, utilizes vast amounts of water, averaging between 1 to 2 million gallons per plant daily across over 2,000 facilities nationwide. These plants discharge water contaminated with blood, oil, grease, fats, ammonia, dangerous fecal bacteria, and antibiotic-r

  • PR Newswire

    CYBER ENVIRO-TECH, INC ACQUIRES STABLEX AND SECURES EXCLUSIVE GLOBAL LICENSES TO INTELLECTUAL PROPERTY RIGHTS FROM KAM BIOTECHNOLOGY LTD.

    (OTC Pink: CETI), Cyber Enviro-Tech, Inc. is pleased to announce the acquisition of the patent for Stablex and the geographic expansion of its license rights for seven proprietary intellectual biotechnology compounds of KAM Biotechnology Ltd ("KAM") from the United States to worldwide. Having initially secured US rights in mid-2023, CETI has opted to extend its exclusive license rights globally in light of promising results observed by several of its domestic and international clients. This stra